We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » AAM Questions FDA’s Product Identifiers in Supply Chain Guidance
AAM Questions FDA’s Product Identifiers in Supply Chain Guidance
Generic drugmakers urged the FDA to allow for more flexibility in draft guidance on product identifiers under the Drug Supply Chain Security Act (DSCSA).